Longevity · Biological Age · Functional Assessment
Your chronological age is fixed. Your biological age — how well your body is actually ageing — is not. The gap between the two is determined by factors that are measurable with functional testing and modifiable with targeted intervention. The question worth asking is not how old you are. It is how old your body is behaving — and whether those two numbers are moving in the same direction.
In 2019 a study published in the British Medical Journal followed over 500,000 adults and found that grip strength predicted all-cause mortality more strongly than systolic blood pressure, resting heart rate, or physical activity level. Not slightly more strongly — substantially more strongly. A weak handgrip in midlife was associated with a 67% increased risk of cardiovascular mortality and a 31% increased risk of all-cause mortality over the follow-up period.
This is not an isolated finding. A 2022 study in the Journal of the American Medical Association found that a single-leg balance test under 10 seconds at age 71 was associated with an 84% higher risk of death from any cause over the following decade, independent of other risk factors. A 2019 Lancet paper on gait speed found that slow walkers had a biological age up to 16 years older than fast walkers of the same chronological age.
These findings matter because they are accessible, cost-nothing to measure, and reflect something about the underlying biology that expensive biomarker panels can miss. A 55-year-old who cannot hold a single-leg balance for 10 seconds, whose gait has slowed measurably over the past five years, and whose handgrip has weakened is telling you something about their neurological integrity, mitochondrial function, and systemic inflammatory burden — without a single blood draw.
But the physical tests and the biochemical markers tell complementary stories. Used together, they give you a complete picture of biological ageing rate that neither provides alone.
In 2013 López-Otín and colleagues published a landmark paper in Cell identifying nine hallmarks of ageing — the biological processes that drive age-related decline. Updated in 2023 to twelve hallmarks. These are not theoretical constructs. They are measurable, and several of them are directly assessable with the functional panels already described on this site.
Accumulated DNA damage from oxidative stress, radiation, and replication errors. The rate of accumulation determines biological ageing speed.
Declining mitochondrial efficiency and increasing mitochondrial reactive oxygen species. The energy production capacity of cells falls with age.
Cells that stop dividing but don't die — secreting inflammatory signals (the SASP) that drive tissue dysfunction in neighbouring cells.
Changes in DNA methylation patterns that alter gene expression without changing the DNA sequence. The epigenetic clock is one of the most accurate biological age measures available.
Declining ability to produce, fold, and clear proteins correctly. Misfolded proteins accumulate — the basis of neurodegeneration in Alzheimer's and Parkinson's.
NAD+ falls by approximately 50% between age 40 and 60. Required for sirtuins (longevity enzymes), DNA repair, and mitochondrial function. One of the most validated longevity targets.
Inflammatory signalling increases with age (inflammaging) while regenerative signalling decreases. The chronic low-grade inflammatory state of ageing drives multiple age-related diseases simultaneously.
Added in the 2023 update. Microbial diversity declines with age. The gut microbiome is increasingly recognised as a central regulator of biological ageing through immune, metabolic, and neuroendocrine mechanisms.
This is the section most practitioners and most clients have never heard of. The Randox Signature blood panel includes three neurological biomarkers that are rarely discussed in functional medicine contexts but have significant longevity implications.
Elevated GFAP, NDKA, or PARK7 in an asymptomatic individual does not diagnose neurodegeneration. These markers reflect neurological stress — which has multiple causes including chronic systemic inflammation, metabolic dysfunction, vascular stress, and sleep deprivation. A single elevated reading warrants investigation of the likely drivers rather than alarm. A trend of increasing values over serial measurements is more clinically significant than any single reading. These markers are most useful as early warning signals prompting deeper investigation — not as diagnostic tests.
The biological age gap is not just a metaphor. Epigenetic clock research — led by Steve Horvath at UCLA and others — has demonstrated that methylation patterns at specific CpG sites in the genome change predictably with age and can be used to calculate a biological age that frequently diverges from chronological age by 5–15 years in either direction. People who are biologically younger than their chronological age have consistently better health outcomes, lower disease risk, and longer lifespan. People who are biologically older than their chronological age show the reverse pattern.
The epigenetic clock is not yet a routine clinical test in the UK. But the functional markers that correlate with biological age — oxidative stress markers, inflammatory markers, mitochondrial function, methylation status, physical performance — are all measurable now with existing tests. You don't need an epigenetic clock to know whether you are ageing faster than you should be. You need the right tests, read together, with someone who knows what the pattern means.
The people who are biologically 10 years younger than their chronological age are not doing something mysterious. They are sleeping well, moving regularly, managing their inflammatory load, maintaining muscle mass, protecting their mitochondria from oxidative stress, and keeping their homocysteine in the optimal range. All measurable. All modifiable. None of it requires a drug.
| Intervention | Evidence level | Primary mechanism | Clinical note |
|---|---|---|---|
| Resistance training | Strong | Preserves muscle mass and power, upregulates mitochondrial biogenesis, reduces inflammatory markers, improves insulin sensitivity | 2–3 sessions/week minimum. Compound movements. Progressive overload. The single most evidence-backed longevity intervention. |
| Zone 2 aerobic training | Strong | Upregulates mitochondrial density and efficiency, improves VO2 max, reduces cardiovascular risk, supports metabolic health | 150–180 minutes/week at conversational pace. The pace where you can speak in full sentences but find it slightly effortful. |
| Creatine monohydrate | Strong | Replenishes phosphocreatine for explosive ATP production, preserves muscle mass, emerging evidence for cognitive protection and neurological longevity | 3–5g daily. Most studied supplement in exercise science. Now emerging as a longevity-relevant intervention well beyond sport. |
| Omega-3 (EPA+DHA) | Strong | Reduces inflammatory eicosanoids, preserves membrane fluidity, supports neurological integrity, reduces cardiovascular risk | Minimum 2g EPA+DHA daily. Omega-3 index target above 8% on fatty acids panel. Higher EPA for cardiovascular and inflammatory presentations. |
| Homocysteine management | Strong | Reduces endothelial damage, protects nitric oxide, reduces neurological and cardiovascular risk — homocysteine is one of the most actionable longevity markers | Methylfolate + methylcobalamin + P5P. Test first. Target below 7 µmol/L on functional criteria. |
| Sleep optimisation | Strong | Glymphatic clearance of neurological waste products (including Alzheimer's-associated amyloid), HGH pulse, immune recalibration, cellular repair | 7–9 hours. Consistent timing. Dark, cool room. Sleep deprivation accelerates biological ageing across multiple hallmark pathways simultaneously. |
| NAD+ precursors (NMN/NR) | Good — emerging | Restores declining NAD+ levels, activates sirtuins (longevity enzymes), supports mitochondrial function and DNA repair | 250–500mg NMN or NR daily. Evidence base growing rapidly. Most compelling for individuals showing mitochondrial markers on OAT and above age 45. |
| Time-restricted eating | Good | Upregulates autophagy (cellular self-cleaning), improves insulin sensitivity, reduces inflammatory markers, supports circadian rhythm alignment | 12–16 hour overnight fast. 8–12 hour eating window. Most practical longevity-adjacent dietary intervention for general population. |
| CoQ10 (ubiquinol) | Good | Mitochondrial electron transport chain cofactor, antioxidant, protects against mitochondrial DNA damage. Declines with age and statin use. | 100–200mg ubiquinol daily with fat. Priority for anyone on a statin, anyone with elevated Krebs cycle markers on OAT, anyone over 50. |
| Cold exposure | Emerging | Activates brown adipose tissue, increases noradrenaline, upregulates mitochondrial biogenesis, anti-inflammatory via IL-10 upregulation | Evidence growing but protocol specifics uncertain. Cold shower, cold water immersion. Promising mechanistically — clinical outcome data accumulating. |
A longevity assessment is not a single test. It is a framework that combines physical performance testing with biochemical markers across multiple systems — because biological ageing is a multi-system process and no single marker captures it.
The physical performance tests — grip strength, gait speed, single-leg balance, chair stand test — take ten minutes and require no equipment beyond a stopwatch. They are the starting point because they give an immediate functional picture that contextualises the biochemical data.
The biochemical layer adds precision. Oxidative stress markers on the Metabolomix+ OAT tell you how fast cells are accumulating DNA damage. Inflammatory markers on the Randox blood chemistry tell you whether the inflammaging process is already established. The neurological markers — GFAP, NDKA, PARK7 — tell you whether the brain is under stress before cognitive symptoms appear. Homocysteine tells you whether the methylation cycle is protecting the cardiovascular and neurological systems as it should. The omega-3 index tells you whether membrane chemistry supports or impairs cellular ageing.
Read together, these give you a biological age estimate that is more useful than the number on your birth certificate — because it tells you not just where you are, but which systems are driving the gap and therefore where the intervention should focus.
There is no intervention that stops ageing. There are interventions that slow the rate at which the hallmarks of ageing accumulate — and functional testing tells you which of those hallmarks are most active in your specific biology. The goal is not immortality. It is maximising the years in which you are fully functional, cognitively intact, and physically capable. The evidence consistently shows that the gap between lifespan and healthspan — the years you are alive but not well — is largely determined by lifestyle and metabolic factors that are modifiable. That is what this assessment is designed to address.
The Randox Signature blood panel includes GFAP, NDKA, PARK7, hsCRP, homocysteine, and up to 180 markers across all major systems. Combined with a Metabolomix+ OAT for oxidative stress and mitochondrial function, and a physical performance assessment, this gives a comprehensive biological age picture with clear intervention priorities.
Book a conversation →